vicc Archives
Photo: Living well through cancer
Jul. 12, 2012—Olympic gold medal skating champion and cancer survivor Scott Hamilton was the keynote speaker at Vanderbilt-Ingram Cancer Center’s annual cancer survivors day event held at the Vanderbilt Student Life Center. Nearly 600 people attended “Going for the Gold: Living Well through Cancer,” which featured activities for cancer patients, survivors, friends and families. (photo by Debra...
New cancer drug shows promise in early testing
Jul. 12, 2012—An experimental drug that activates T-cells and promotes an immune response to fight tumors has shown promising early results in patients with kidney cancer, melanoma and non-small cell lung cancer. Vanderbilt-Ingram Cancer Center investigators Leora Horn, M.D., Jeffrey Sosman, M.D., and researchers from several other cancer centers tested the new compound. The results of the...
Vanderbilt identifies genes linked to breast cancer chemo resistance
Jun. 11, 2012—A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
New drug mutes more melanomas
Apr. 26, 2012—An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
Factor sensitizes cancer to radiation
Apr. 6, 2012—Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy.
Smoking stokes cells’ cancer capacity
Mar. 23, 2012—Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk.
Urine biomarker for colon cancer?
Mar. 10, 2012—A molecule detectable in urine may be helpful in diagnosing colon cancer.
Sosman named to ‘Dream Team’ of cancer investigators
Jan. 5, 2012—Jeffrey Sosman, M.D., professor of Medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by Stand Up To Cancer (SU2C) and the Melanoma Research Alliance (MRA). Sosman is among the Dream Team’s principal investigators who will work closely with the other principal clinical investigators to...
Hope notes
Jan. 5, 2012—Vanderbilt-Ingram Cancer Center patients, families and staff members recently placed messages of hope and requests for cancer research funds on a “Wall of Hope” at the Cancer Center. The American Cancer Society Cancer Action Network sponsored the “Wall of Hope” initiative and will send the messages to members of Tennessee’s congressional delegation.
Protein family key to aging linked to suppressing tumors
Oct. 28, 2011—The list of aging-associated proteins known to be involved in cancer is growing longer, according to research by investigators at Vanderbilt-Ingram Cancer Center and the National Institutes of Health.
Fungus toxin gets in the way in DNA
Oct. 7, 2011—Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.
University earns CEO Gold Standard Award for cancer prevention
Jul. 27, 2011—Vanderbilt University Medical Center, in conjunction with the Vanderbilt-Ingram Cancer Center, has been re-accredited as a CEO Cancer Gold Standard employer for 2011. The award is based on Vanderbilt’s efforts to help employees lead healthier lives, including activities that may help prevent cancer.
